Dr. Taisei John Kobayashi, MD

Dr. Kobayashi practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Kobayashi's NPI, 1992936306, was assigned on August 3, 2009. Dr. Kobayashi graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2010. Dr. Kobayashi holds Pennsylvania license MD446676.

Dr. Kobayashi's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Kobayashi's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Kobayashi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kobayashi practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kobayashi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kobayashi is licensed in Pennsylvania.

CMS data shows 300 Medicare services from Dr. Kobayashi across 9 procedure codes in 2024, for 156 Medicare patients. Medicare paid $16,149 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 156 Medicare patients who saw Dr. Kobayashi in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kobayashi's median patient age at 68, with 36% women.

In 2024, Dr. Kobayashi wrote 69 Medicare Part D claims for 17 patients. 57% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $226 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kobayashi for performance year 2024, reported as part of a group. Dr. Kobayashi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kobayashi as offering telehealth. CMS counts 29 procedures of coronary angioplasty and stenting by Dr. Kobayashi, more than 64% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 207 general payments to Dr. Kobayashi from 9 drug and device companies from 2024 to 2025. Acquisitions make up the largest share, 62% of the total. Boston Scientific Corporation paid the most, $204,891.

Dr. Kobayashi graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2010.